PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis ; volume:19 ; number:1 ; day:28 ; month:10 ; year:2019 ; pages:1-4 ; date:12.2019
Cancer cell international ; 19, Heft 1 (28.10.2019), 1-4, 12.2019
- Urheber
-
Palmieri, Maria
Baldassarri, Margherita
Fava, Francesca
Fabbiani, Alessandra
Campennì, Giuseppe Maria
Mencarelli, Maria Antonietta
Tita, Rossella
Marsili, Stefania
Renieri, Alessandra
Frullanti, Elisa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-019-0991-y
- URN
-
urn:nbn:de:101:1-2020022621134913756022
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Palmieri, Maria
- Baldassarri, Margherita
- Fava, Francesca
- Fabbiani, Alessandra
- Campennì, Giuseppe Maria
- Mencarelli, Maria Antonietta
- Tita, Rossella
- Marsili, Stefania
- Renieri, Alessandra
- Frullanti, Elisa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer
Carcinogenesis of PIK3CA
PIK3CA-mutations in breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer
Carcinogenesis of PIK3CA
PIK3CA-mutations in breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer
Carcinogenesis of PIK3CA
PIK3CA-mutations in breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions